Literature DB >> 32881766

Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury.

Hilaire J Thompson1, Sarah R Martha, Jin Wang, Kyra J Becker.   

Abstract

OBJECTIVE: To compare plasma inflammatory biomarker concentrations to 6 months in young and older adults with and without mild traumatic brain injury (TBI).
SETTING: Level 1 trauma center. PARTICIPANTS: Younger (21-54 years) and older (55+) adults diagnosed with mild TBI along with age-/sex-matched noninjured controls (n = 313).
DESIGN: Prospective cohort study. MAIN MEASURES: Multiplex assays were used to quantify concentrations of selected plasma inflammatory markers at day 0, months 1 and 6.
RESULTS: Persistent aging-related differences were found between control groups in concentrations of 4 cytokines up to 6 months. At day 0, interleukin-6 (IL-6), IL-8, and fractalkine were higher in the older TBI compared with older control as well as the younger TBI groups, while IL-10 was higher in older TBI compared with controls. At month 1, significantly higher concentrations of IL-8, fractalkine, and tumor necrosis factor-α (TNF-α) were seen. At 6 months postinjury, significantly higher concentrations of IL-6 and IL-8 were seen, while a lower concentration of IL-7 was found in older versus younger TBI groups.
CONCLUSION: The neuroinflammatory signature that accompanies mild TBI in older adults differs from that of younger adults. The differences seen are notable for their roles in neutrophil attraction (IL-8), neuronal-microglial-immune cell interactions (fractalkine), and chronic inflammation (IL-6).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32881766      PMCID: PMC7479638          DOI: 10.1097/HTR.0000000000000606

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   3.117


  63 in total

Review 1.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

2.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

3.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

Authors:  M Romano; M Sironi; C Toniatti; N Polentarutti; P Fruscella; P Ghezzi; R Faggioni; W Luini; V van Hinsbergh; S Sozzani; F Bussolino; V Poli; G Ciliberto; A Mantovani
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

4.  Impact of aging on the immune response to traumatic brain injury (AIm:TBI) study protocol.

Authors:  Hilaire J Thompson; Frederick Rivara; Kyra J Becker; Ronald Maier; Nancy Temkin
Journal:  Inj Prev       Date:  2019-09-03       Impact factor: 2.399

Review 5.  Proinflammatory cytokines, aging, and age-related diseases.

Authors:  Martin Michaud; Laurent Balardy; Guillaume Moulis; Clement Gaudin; Caroline Peyrot; Bruno Vellas; Matteo Cesari; Fati Nourhashemi
Journal:  J Am Med Dir Assoc       Date:  2013-06-20       Impact factor: 4.669

Review 6.  Traumatic brain injury in older adults: epidemiology, outcomes, and future implications.

Authors:  Hilaire J Thompson; Wayne C McCormick; Sarah H Kagan
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

Review 7.  Inflammation and neuroprotection in traumatic brain injury.

Authors:  Kara N Corps; Theodore L Roth; Dorian B McGavern
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

8.  Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury.

Authors:  B Maier; K Schwerdtfeger; A Mautes; M Holanda; M Müller; W I Steudel; I Marzi
Journal:  Shock       Date:  2001-06       Impact factor: 3.454

9.  Fractalkine and fractalkine receptors in human neurons and glial cells.

Authors:  Kozo Hatori; Atsushi Nagai; Rochelle Heisel; Jae K Ryu; Seung U Kim
Journal:  J Neurosci Res       Date:  2002-08-01       Impact factor: 4.164

10.  Inflamm-aging does not simply reflect increases in pro-inflammatory markers.

Authors:  Vincent Morrisette-Thomas; Alan A Cohen; Tamàs Fülöp; Éléonor Riesco; Véronique Legault; Qing Li; Emmanuel Milot; Françis Dusseault-Bélanger; Luigi Ferrucci
Journal:  Mech Ageing Dev       Date:  2014-07-08       Impact factor: 5.432

View more
  4 in total

1.  Aging with Traumatic Brain Injury: Deleterious Effects of Injury Chronicity Are Most Pronounced in Later Life.

Authors:  Amanda R Rabinowitz; Raj G Kumar; Adam Sima; Umesh M Venkatesan; Shannon B Juengst; Therese M O'Neil-Pirozzi; Thomas K Watanabe; Yelena Goldin; Flora M Hammond; Laura E Dreer
Journal:  J Neurotrauma       Date:  2021-07-20       Impact factor: 4.869

2.  Potential Progression Mechanism and Key Genes in Early Stage of mTBI.

Authors:  Hu Zhou; Xue Han; Hui-Xia Zhou; Zhen-Zhen Cao; Li Yang; Jian-Yun Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

Review 3.  Correlation between Mild Traumatic Brain Injury-Induced Inflammatory Cytokines and Emotional Symptom Traits: A Systematic Review.

Authors:  Shazia Malik; Omar Alnaji; Mahnoor Malik; Teresa Gambale; Michel Piers Rathbone
Journal:  Brain Sci       Date:  2022-01-12

4.  Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury.

Authors:  Adel Helmy; Eric Peter Thelin; Philipp Lassarén; Caroline Lindblad; Arvid Frostell; Keri L H Carpenter; Mathew R Guilfoyle; Peter J A Hutchinson
Journal:  J Neuroinflammation       Date:  2021-09-25       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.